Higher serum carcinoembryonic antigen levels associate with more frequent development of incident fractures in Korean women: A longitudinal study using the national health insurance claim data

Bone

Volumn 73, Issue , 2015, Pages 190-197

  Kim, Beom Jun ^a   Baek, Seunghee ^a   Lee, Seung Hun ^a   Ahn, Seong Hee ^a   Kim, Hyeon Mok ^a   Kim, Seon Ha ^b   Jo, Min Woo ^a   Bae, Sung Jin ^a   Kim, Hong Kyu ^a   Choe, Jaewon ^a   Park, Gyung Min ^a   Kim, Young Hak ^a   Kim, Ghi Su ^a   Koh, Jung Min ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Bone mineral density; Carcinoembryonic antigen; Fracture; Inflammation

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARCINOEMBRYONIC ANTIGEN; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CARCINOEMBRYONIC ANTIGEN BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; FRACTURE; HEALTH INSURANCE; HUMAN; ICD-10; KOREAN (PEOPLE); LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SPINE FRACTURE; WOMEN'S HEALTH; BLOOD; FRACTURES, BONE; MIDDLE AGED; PUBLIC HEALTH; RISK FACTOR; SOUTH KOREA;

BIOMARKERS; BONE DENSITY; CARCINOEMBRYONIC ANTIGEN; CROSS-SECTIONAL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84920988726     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.12.016     Document Type: Article

References (37)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-95.
2. Lorenzo J., Horowitz M., Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 2008, 29:403-440.
3. Krupey J., Wilson T., Freedman S.O., Gold P. The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry 1972, 9:617-622.
4. Yalta K., Yilmaz A., Turgut O.O., Erselcan T., Yilmaz M.B., Karadas F., et al. Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction. Adv. Ther. 2006, 23:1052-1059.
5. Fukuda I., Yamakado M., Kiyose H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J. Med. Syst. 1998, 22:89-93.
6. Ruibal Morell A. CEA serum levels in non-neoplastic disease. Int. J. Biol. Markers 1992, 7:160-166.
7. Witherspoon L.R., Shuler S.E., Alyea K., Husserl F.E. Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure. J. Nucl. Med. 1983, 24:916-921.
8. Ishizaka N., Ishizaka Y., Toda E., Koike K., Yamakado M., Nagai R. Are serum carcinoembryonic antigen levels associated with carotid atherosclerosis in Japanese men?. Arterioscler. Thromb. Vasc. Biol. 2008, 28:160-165.
9. Lee J.W., Park K.D., Im J.A., Hwang H.J., Kim S.H. Serum carcinoembryonic antigen is associated with metabolic syndrome in female Korean non-smokers. Clin. Chim. Acta 2011, 412:527-530.
10. Aarons C.B., Bajenova O., Andrews C., Heydrick S., Bushell K.N., Reed K.L., et al. Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. Clin. Exp. Metastasis 2007, 24:201-209.
11. Ganguly A., Yeltsin E., Robbins J. Identification of a carcinoembryonic antigen binding protein on monocytes. Biochem. Biophys. Res. Commun. 2003, 311:319-323.
12. Kiel D. Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J. Bone Miner. Res. 1995, 10:518-523.
13. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 1993, 8:1137-1148.
14. Choi H.J., Shin C.S., Ha Y.C., Jang S., Park C., Yoon H.K., et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J. Bone Miner. Metab. 2012, 30:54-58.
15. Kang H.Y., Yang K.H., Kim Y.N., Moon S.H., Choi W.J., Kang D.R., et al. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data. BMC Public Health 2010, 10:230.
16. Lee Y.K., Ha Y.C., Park C., Yoo J.J., Shin C.S., Koo K.H. Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos. Int. 2013, 24:707-711.
17. Lippuner K., Johansson H., Kanis J.A., Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos. Int. 2009, 20:1131-1140.
18. Park C., Ha Y.C., Jang S., Yoon H.K., Lee Y.K. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J. Bone Miner. Metab. 2011, 29:744-751.
19. Seeley D.G., Browner W.S., Nevitt M.C., Genant H.K., Scott J.C., Cummings S.R. Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann. Intern. Med. 1991, 115:837-842.
20. Bae U., Shim J.Y., Lee H.R., Shin J.Y. Serum carcinoembryonic antigen level is associated with arterial stiffness in healthy Korean adult. Clin. Chim. Acta 2013, 415:286-289.
21. Belluco C., Nitti D., Frantz M., Toppan P., Basso D., Plebani M., et al. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann. Surg. Oncol. 2000, 7:133-138.
22. Ishii S., Cauley J.A., Greendale G.A., Crandall C.J., Danielson M.E., Ouchi Y., et al. C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J. Bone Miner. Res. 2013, 28:1688-1698.
23. Pasco J.A., Kotowicz M.A., Henry M.J., Nicholson G.C., Spilsbury H.J., Box J.D., et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006, 296:1353-1355.
24. Schett G., Kiechl S., Weger S., Pederiva A., Mayr A., Petrangeli M., et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch. Intern. Med. 2006, 166:2495-2501.
25. Vasikaran S.D. Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Crit. Rev. Clin. Lab. Sci. 2008, 45:221-258.
26. Duffy M.J. Tumor markers in clinical practice: a review focusing on common solid cancers. Med. Princ. Pract. 2013, 22:4-11.
27. Meissner H.I., Breen N., Klabunde C.N., Vernon S.W. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol. Biomarkers Prev. 2006, 15:389-394.
28. National Osteoporosis Foundation The Clinician's Guide to Prevention and Treatment of Osteoporosis Version 1 2014, National Osteoporosis Foundation, Washington.
29. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
30. Garnero P., Sornay-Rendu E., Claustrat B., Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J. Bone Miner. Res. 2000, 15:1526-1536.
31. Johnell O., Oden A., De Laet C., Garnero P., Delmas P.D., Kanis J.A. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos. Int. 2002, 13:523-526.
32. Tremollieres F.A., Pouilles J.M., Drewniak N., Laparra J., Ribot C.A., Dargent-Molina P. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J. Bone Miner. Res. 2010, 25:1002-1009.
33. Bormer O.P. Standardization, specificity, and diagnostic sensitivity of four immunoassays for carcinoembryonic antigen. Clin. Chem. 1991, 37:231-236.
34. Hendriks H.A., Kortlandt W., Verweij W.M. Analytical performance comparison of five new generation immunoassay analyzers. Ned Tijdschr Klin Chem. 2000, 25:170-177.
35. Hubl W., Zogbaum M., Boyd J.C., Savory J., Schubert M., Meyer D., et al. Evaluation of analytical methods and workflow performance of the Architect ci8200 integrated serum/plasma analyzer system. Clin. Chim. Acta 2005, 357:43-54.
36. De Coster C., Quan H., Finlayson A., Gao M., Halfon P., Humphries K.H., et al. Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv. Res. 2006, 6:77.
37. Kanis J.A., Johnell O., Oden A., Sembo I., Redlund-Johnell I., Dawson A., et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporos. Int. 2000, 11:669-674.